Artrya Limited (ASX:AYA)

Australia flag Australia · Delayed Price · Currency is AUD
3.380
-0.080 (-2.31%)
At close: Feb 5, 2026
293.02%
Market Cap534.32M +508.4%
Revenue (ttm)28.00K
Net Income-16.41M
EPS-0.18
Shares Out158.08M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume671,757
Average Volume624,250
Open3.460
Previous Close3.460
Day's Range3.350 - 3.510
52-Week Range0.560 - 5.240
Beta0.55
RSI35.18
Earnings DateFeb 1, 2026

About Artrya

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia. [Read more]

Sector Healthcare
Founded 2018
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol AYA
Full Company Profile

Financial Performance

Financial Statements